Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of Meptin Swinghaler and Berotec N Metered Aerosol in adults with mild to moderate stable asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Berotec N Metered Aerosol
• Meptin Swinghaler (metaproterenol)

Snippet

Sponsor: Taiwan Otsuka Pharm. Co., Ltd | Conditions: Asthma | Phase 3 | Status: COMPLETED